233 related articles for article (PubMed ID: 32036231)
1. Progress toward the development of the small molecule equivalent of small interfering RNA.
Disney MD; Suresh BM; Benhamou RI; Childs-Disney JL
Curr Opin Chem Biol; 2020 Jun; 56():63-71. PubMed ID: 32036231
[TBL] [Abstract][Full Text] [Related]
2. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence.
Disney MD; Angelbello AJ
Acc Chem Res; 2016 Dec; 49(12):2698-2704. PubMed ID: 27993012
[TBL] [Abstract][Full Text] [Related]
3. How We Think about Targeting RNA with Small Molecules.
Costales MG; Childs-Disney JL; Haniff HS; Disney MD
J Med Chem; 2020 Sep; 63(17):8880-8900. PubMed ID: 32212706
[TBL] [Abstract][Full Text] [Related]
4. Targeted Degradation of a Hypoxia-Associated Non-coding RNA Enhances the Selectivity of a Small Molecule Interacting with RNA.
Costales MG; Suresh B; Vishnu K; Disney MD
Cell Chem Biol; 2019 Aug; 26(8):1180-1186.e5. PubMed ID: 31130520
[TBL] [Abstract][Full Text] [Related]
5. Small molecule recognition of disease-relevant RNA structures.
Meyer SM; Williams CC; Akahori Y; Tanaka T; Aikawa H; Tong Y; Childs-Disney JL; Disney MD
Chem Soc Rev; 2020 Oct; 49(19):7167-7199. PubMed ID: 32975549
[TBL] [Abstract][Full Text] [Related]
6. Re-Engineering RNA Molecules into Therapeutic Agents.
Egli M; Manoharan M
Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
[TBL] [Abstract][Full Text] [Related]
7. Identifying and validating small molecules interacting with RNA (SMIRNAs).
Disney MD; Velagapudi SP; Li Y; Costales MG; Childs-Disney JL
Methods Enzymol; 2019; 623():45-66. PubMed ID: 31239057
[TBL] [Abstract][Full Text] [Related]
8. Speeding drug discovery targeting RNAs: An iterative "RNA selection-compounds screening cycle" for exploring RNA-small molecule pairs.
Furuzono T; Murata A; Okuda S; Mizutani K; Adachi T; Nakatani K
Bioorg Med Chem; 2021 Apr; 36():116070. PubMed ID: 33773376
[TBL] [Abstract][Full Text] [Related]
9. Design of small molecules targeting RNA structure from sequence.
Ursu A; Childs-Disney JL; Andrews RJ; O'Leary CA; Meyer SM; Angelbello AJ; Moss WN; Disney MD
Chem Soc Rev; 2020 Oct; 49(20):7252-7270. PubMed ID: 32935689
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer.
Costales MG; Aikawa H; Li Y; Childs-Disney JL; Abegg D; Hoch DG; Pradeep Velagapudi S; Nakai Y; Khan T; Wang KW; Yildirim I; Adibekian A; Wang ET; Disney MD
Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2406-2411. PubMed ID: 31964809
[TBL] [Abstract][Full Text] [Related]
11. Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs.
Velagapudi SP; Costales MG; Vummidi BR; Nakai Y; Angelbello AJ; Tran T; Haniff HS; Matsumoto Y; Wang ZF; Chatterjee AK; Childs-Disney JL; Disney MD
Cell Chem Biol; 2018 Sep; 25(9):1086-1094.e7. PubMed ID: 30251629
[TBL] [Abstract][Full Text] [Related]
12. Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs.
Disney MD; Winkelsas AM; Velagapudi SP; Southern M; Fallahi M; Childs-Disney JL
ACS Chem Biol; 2016 Jun; 11(6):1720-8. PubMed ID: 27097021
[TBL] [Abstract][Full Text] [Related]
13. Drugging the "undruggable" microRNAs.
Liu D; Wan X; Shan X; Fan R; Zha W
Cell Mol Life Sci; 2021 Mar; 78(5):1861-1871. PubMed ID: 33052435
[TBL] [Abstract][Full Text] [Related]
14. Design of a small molecule against an oncogenic noncoding RNA.
Velagapudi SP; Cameron MD; Haga CL; Rosenberg LH; Lafitte M; Duckett DR; Phinney DG; Disney MD
Proc Natl Acad Sci U S A; 2016 May; 113(21):5898-903. PubMed ID: 27170187
[TBL] [Abstract][Full Text] [Related]
15. Understanding the characteristics of nonspecific binding of drug-like compounds to canonical stem-loop RNAs and their implications for functional cellular assays.
Kelly ML; Chu CC; Shi H; Ganser LR; Bogerd HP; Huynh K; Hou Y; Cullen BR; Al-Hashimi HM
RNA; 2021 Jan; 27(1):12-26. PubMed ID: 33028652
[TBL] [Abstract][Full Text] [Related]
16. Targeting RNA with Small Molecules To Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine.
Disney MD
J Am Chem Soc; 2019 May; 141(17):6776-6790. PubMed ID: 30896935
[TBL] [Abstract][Full Text] [Related]
17. Approaches to Validate and Manipulate RNA Targets with Small Molecules in Cells.
Childs-Disney JL; Disney MD
Annu Rev Pharmacol Toxicol; 2016; 56():123-40. PubMed ID: 26514201
[TBL] [Abstract][Full Text] [Related]
18. Affecting RNA biology genome-wide by binding small molecules and chemically induced proximity.
Baisden JT; Childs-Disney JL; Ryan LS; Disney MD
Curr Opin Chem Biol; 2021 Jun; 62():119-129. PubMed ID: 34118759
[TBL] [Abstract][Full Text] [Related]
19. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis.
Vickers TA; Koo S; Bennett CF; Crooke ST; Dean NM; Baker BF
J Biol Chem; 2003 Feb; 278(9):7108-18. PubMed ID: 12500975
[TBL] [Abstract][Full Text] [Related]
20. Bottom-up design of small molecules that stimulate exon 10 skipping in mutant MAPT pre-mRNA.
Luo Y; Disney MD
Chembiochem; 2014 Sep; 15(14):2041-4. PubMed ID: 25115866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
